GX Acquisition Corp. Information Request Form

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of GX Acquisition Corp. (“GX” or the “Company”) (NASDAQ: GXGX) with Celularity Inc. Upon closing of the business combination, GX Acquisition Corp. will be renamed Celularity Inc., and its common stock and warrants are expected to remain listed on Nasdaq under the new ticker symbols “CELU” and “CELUW.” The public stockholders of GX will own 17% of the post-close CELU.

The GX merger investigation concerns whether the Board of GX has harmed stockholders by agreeing to enter into this transaction and whether all material facts have been properly disclosed to stockholders.